Home Tags SH Institut fur Stoffwechselforschung GmbH

SH Institut fur Stoffwechselforschung GmbH Related Content

iPDM

iPDM Goes Europe: The impact on diabetes and patient care

Here, the tangible impact on diabetes patients and their care is thoroughly explored via integrated personalised diabetes management (iPDM).
clinical contact research

Clinical Contract Research: Building the digital bridge between clinical research and clinical care

Prof Dr Freimut Schliess, Director, Science & Innovation at Profil GmbH, sheds light on how Clinical Contract Research Organisations are building the digital bridge connecting clinical research and clinical care.
chronic care

A life- and disease course approach to health protection and chronic care

Taking advantage of data and trustworthy collaboration is the way to go when it comes to a life- and disease course approach to health protection and chronic care, argues Prof Dr Freimut Schliess, Director of Science & Innovation at Profil GmbH.
didgital innovation

Digital innovation in diabetes: From health promotion to integrated care provision

Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH shares his views on data-based solutions for diabetes.

Follow Open Access Government